(Q30877713)

27 June 2017

title

Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis (English)

1 reference

capillary electrophoresis

27 June 2017

main subject

0 references

0 references

1 reference

Nina Griese

1

1 reference

27 June 2017

Gottfried Blaschke

series ordinal

2

1 reference

27 June 2017

Joachim Boos

series ordinal

3

1 reference

27 June 2017

Georg Hempel

series ordinal

4

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Journal of Chromatography

27 June 2017

published in

1 reference

27 June 2017

volume

979

1 reference

27 June 2017

issue

1-2

1 reference

27 June 2017

page(s)

379-388

1 reference

describes a project that uses

27 June 2017

capillary electrophoresis

1 reference

Impact of scheduling on toxicity and clinical efficacy of doxorubicin: what do we know in the mid-nineties?

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Development of the model of rat isolated perfused heart for the evaluation of anthracycline cardiotoxicity and its circumvention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Liposomal daunorubicin (DaunoXome) in combination with cyclophosphamide, vincristine and prednisolone (COP-X) as salvage therapy in poor-prognosis non-Hodgkins lymphoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Phase I study of liposomal daunorubicin in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

7 January 2021

inferred from DOI database lookup

Bioanalysis of some anthracyclines in human plasma by capillary electrophoresis with laser-induced fluorescence detection

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Therapeutic drug monitoring of doxorubicin in paediatric oncology using capillary electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Anthracycline Efficacy in vitro: Cytotoxicity of Liposomal/Nonliposomal Daunorubicin and Doxorubicin for Multiple Tumor Cell Types

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Charge effect in the interaction of doxorubicin and derivatives with polydeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Kinetic modeling of liposome degradation in blood circulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Distribution of daunorubicin and daunorubicinol in human glioma tumors after administration of liposomal daunorubicin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

7 January 2021

inferred from DOI database lookup

Determination of idarubicin and idarubicinol in plasma by capillary electrophoresis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2802%2901440-1

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0021-9673(02)01440-1

1 reference

27 June 2017

1 reference